ANZCTR search results

The aims of this project are to: - Monitor the benefits and risks of slowly reducing the dosage of previous antipsychotic medicine, while taking aripiprazole. We expect that either of the reductions, unlike sudden discontinuation, will prevent a relapse of your illness. - Assess the side effects and changes in mental state weekly during tapering, and the remainder of the 12 weeks study. We expect that the slower of the two reductions will be accompanied by fewer side effects. - Assess weight, and other complications of obesity, over a period of 12 weeks. We expect weight gain to cease, or even reverse. - Assess psychological and other brain functions over 12 weeks. We expect that thinking, remembering, coordination etc., will improve. - Assess sexual interest and performance over three months. We expect these to improve for patients previously taking medicines known to have these side effects.

: To assess response to Botox injections of the pelvic floor in women with documented pelvic floor muscle spasm with regards to pain, quality of life and anxiety state and to determine an efficacy curve and dosage intervals for repeat injections.